Serum cytochrome c and m30-neoepitope of cytokeratin-18 in chronic hepatitis C. - Wikidata - awgldk - TriplyDB

Serum cytochrome c and m30-neoepitope of cytokeratin-18 in chronic hepatitis C.

Serum cytochrome c and m30-neoepitope of cytokeratin-18 in chronic hepatitis C.

http://www.wikidata.org/entity/Q42249715

about

New Prognostic Biomarkers in Patients With Traumatic Brain Injury Cell death biomarker M65 is a useful indicator of liver inflammation and fibrosis in chronic hepatitis B: A cross-sectional study of diagnostic accuracy Serum levels of caspase-cleaved cytokeratin-18 and mortality are associated in severe septic patients: pilot study Serum levels of caspase-cleaved cytokeratin-18 in patients with severe traumatic brain injury are associated with mortality: a pilot study.Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver.Serum Cytokeratin 18 M30 Levels in Chronic Hepatitis B Reflect Both Phase and Histological Activities of Disease.(Cleaved) CK18 serum and tissue expression levels differentiate acute HCV reinfection from acute rejection in liver allografts.Association between serum levels of caspase-cleaved cytokeratin-18 and early mortality in patients with severe spontaneous intracerebral hemorrhage.High serum levels of caspase-cleaved cytokeratin-18 are associated with malignant middle cerebral artery infarction patient mortality.Progress in non-invasive detection of liver fibrosis.

P2860

Q26768672-B75F4A99-E351-46DE-808E-97B4D205F72D Q33714356-6FE46D54-BAD3-42C3-81E2-DFCBE12E7958 Q34301831-59552414-7949-42C6-BAC0-85FB4AD09AB3 Q35231584-CF2E588C-0AD1-497C-B5BA-7FD4ECD32A5B Q38725581-F1336949-C78E-4FB8-885F-E9798764A2B4 Q40084913-3542451B-E4D7-447D-9CB4-CD3291885532 Q42223298-6FAD90C1-EA08-4758-9426-D51DE0B5695E Q52585124-3A21A5F5-8744-48D9-AEA2-CFF15223C259 Q52638531-504578A3-B36B-4A07-BB7D-8F2F517859AA Q55421930-BA647FE5-58A8-41B3-BF6D-293A8842F8F5

P2860

Serum cytochrome c and m30-neoepitope of cytokeratin-18 in chronic hepatitis C.

http://www.wikidata.org/entity/Q42249715

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Serum cytochrome c and m30-neoepitope of cytokeratin-18 in chronic hepatitis C.

@en

Serum cytochrome c and m30-neoepitope of cytokeratin-18 in chronic hepatitis C.

@nl

type

label

Serum cytochrome c and m30-neoepitope of cytokeratin-18 in chronic hepatitis C.

@en

Serum cytochrome c and m30-neoepitope of cytokeratin-18 in chronic hepatitis C.

@nl

prefLabel

Serum cytochrome c and m30-neoepitope of cytokeratin-18 in chronic hepatitis C.

@en

Serum cytochrome c and m30-neoepitope of cytokeratin-18 in chronic hepatitis C.

@nl

P1433

Q42249715-BD541F57-8D2F-48B2-9B73-9693E7B1B312

P1476

Q42249715-442BADDF-4C0B-4EC6-A6C4-B643B420F1E9

P2093

Q42249715-11384A59-2158-447B-8E90-14120C4EAE9C

P2860

Q42249715-0B825FAA-8F13-4F7A-B13E-BEA0C8FD9424

Q42249715-0CCB26EB-574E-4656-92B7-35BA8ECDB49D

Q42249715-1A969033-B6C8-4C5C-8524-CAF999CC8B6E

Q42249715-2B62BA0F-D515-4CAA-A401-1D8B38585B77

Q42249715-2FF68A8C-7258-49EA-935B-47BCE2D28F8E

Q42249715-328100F6-BD27-4EEF-8687-4187F3AEA202

Q42249715-38CABEAB-6D66-4203-8BD3-FC56F7606201

Q42249715-4A426620-8D51-4569-BBEF-542C564F4173

Q42249715-59D8F4B1-E807-4D0B-B97E-529AB497600D

Q42249715-5FFFAFF1-0A8E-4520-96BF-DF1C58BE54FB

P304

Q42249715-E965B4BB-1AB6-494E-8100-0A5988646112

P31

Q42249715-46764DD5-6F1B-4B89-B0F6-11BDEA7CF57C

P356

Q42249715-DB13A959-74CF-46B2-9100-694682039FBB

P433

Q42249715-5FE5373D-A168-4F46-9536-B72A2D78BF75

P478

Q42249715-3A44211B-F8E0-43CE-9357-4F9C80F8FF8A

P50

Q42249715-2A961958-7708-49D5-9571-DEC08A07FEF8

Q42249715-49CBE740-2E68-4ECC-96DA-AF5AEEAA963C

Q42249715-75BF27D0-4DD8-4D9B-AF53-AE1FE928C0EF

Q42249715-7E0D3782-87B7-4177-A63A-3EF8EC516970

Q42249715-8CE7CFB3-7044-4ED1-A363-62001FD0D5C8

Q42249715-BBD0E1F1-AA7D-4F45-857C-4689B3EF694E

P577

Q42249715-2FE428B1-D0E6-43E7-BF08-DC80A8A21CE4

P698

Q42249715-499AA2BC-DDAC-42FF-AD24-3D1BC061596B

P356

P1433

Liver International

P1476

Serum cytochrome c and m30-neoepitope of cytokeratin-18 in chronic hepatitis C

@en

P2093

Anatol Panasiuk

http://www.w3.org/2001/XMLSchema#string

P2860

Cytochrome c release upon Fas receptor activation depends on translocation of full-length bid and the induction of the mitochondrial permeability transition

Apoptosis in the pathogenesis and treatment of disease

A novel assay for discovery and characterization of pro-apoptotic drugs and for monitoring apoptosis in patient sera.

Total and caspase-cleaved cytokeratin 18 in chronic cholecystitis: a prospective study.

More than one way to die: apoptosis, necrosis and reactive oxygen damage.

Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis.

Apoptosis and liver disease.

HCV NS4B induces apoptosis through the mitochondrial death pathway.

Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury.

Serum apoptosis markers related to liver damage in chronic hepatitis C: sFas as a marker of advanced fibrosis in children and adults while M30 of severe steatosis only in children.

P304

544-550

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/LIV.12297

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

Magdalena Świderska

Anna Parfieniuk-Kowerda

Jerzy Jaroszewicz

M Rogalska-Płońska

P577

2013-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23981197

http://www.w3.org/2001/XMLSchema#string